4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Wai Chun Bio-Technology Limited (0660) operates in the Chemicals industry and is headquartered in Wan Chai, Hong Kong with about 63 employees. Its market capitalization is roughly HKD 188 million. In the fiscal year ended 2025-06-30, 0660 reported HKD 377M in revenue and (HKD 15M) in net income.
Wai Chun Bio-Technology Limited, an investment holding company, engages in the manufacture and sale of modified starch and other biochemical products in the People's Republic of China.
Interactive charts & full statements →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue | HKD 377M | HKD 370M | HKD 774M | HKD 495M |
| Gross Profit | HKD 36M | HKD 34M | HKD 50M | HKD 38M |
| Operating Income (EBIT) | HKD 1M | HKD 1M | HKD 14M | HKD 2M |
| Net Income | (HKD 15M) | (HKD 44M) | (HKD 15M) | (HKD 17M) |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | HKD 215M | HKD 210M | HKD 240M | HKD 250M | — |
| Total Liabilities | HKD 277M | HKD 265M | HKD 230M | HKD 244M | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0660 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms